ProQR Therapeutics (PRQR) said Monday it appointed Dennis Hom as chief financial officer and Cristina Lopez as chief medical officer.
Hom joins the company from Sagimet Biosciences (SGMT), where he most recently was head of corporate development and CFO, ProQR added. He will succeed Jurriaan Dekkers, who is stepping down as finance chief but will remain during the transition period.
Lopez most recently served as global head of neurodegeneration at Johnson & Johnson (JNJ).
ProQR's stock was down 2.2% in recent Monday trading.
Price: 1.10, Change: -0.03, Percent Change: -2.23
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.